← All organizations
Highest phase reached
Phase 1
First clinical trial
Dec 31, 2020Last known activity
Dec 31, 2020
Acquired by Neurogene Inc. on Jul 18, 2023
Timeline
2000s
- Dec 15, 2003
Neoleukin— Founded
2020s
- Jul 18, 2023
Neurogene Inc.— Acquired By
Drugs by trial phase (1 distinct, 1 trials)
Phase 1 (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (1)
- NCT04659629Study directorPhase 1Dec 31, 2020
Details
- Founded
- Seattle, WA, US Dec 15, 2003
- Last known activity
- Dec 31, 2020